Durvalumab vs Vancomycin

## Durvalumab vs Vancomycin: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Vancomycin**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Vancomycin**: Glycopeptide antibiotic inhibiting cell wall synthesis by binding D-Ala-D-Ala terminus of peptidoglycan precursors.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Vancomycin — 4-6 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Vancomycin — C66H75Cl2N9O24.

**Molecular Weight**: Durvalumab — N/A; Vancomycin — 1449.2500 g/mol.

**Type**: Durvalumab — Antibody; Vancomycin — Small molecule.